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It was almost thirty years ago that the first indication of the involvement of neurohypo- 
physial peptides in cognitive processes was reported. It was found that the removal 
of the posterior pituitary gland, an intervention that disturbed pituitary-adrenal respon- 
siveness to emotional stressors, also impaired the maintenance of an avoidance behavior 
in the rat. This deficit could be restored by treatment with vasopressin. That vasopres- 
sin also normalized impaired avoidance learning behavior of hypophysectomized rats 
indicated that this effect was not due to the release of adrenocorticotroph hormone 
or related neuroactive peptides from the anterior pituitary.2 Vasopressin administration 
in the intact rat caused a long-term maintenance of active avoidance behav i~ r .~  The 
hypothesis was formulated that vasopressin affected long-term memory processes. Fi- 
nally in the seventies, it became clear that oxytocin, although it frequently mimicked 
the effects of vasopressin, had intrinsic behavioral activity of an opposite nature, and 
was regarded as an amnesic neuropeptide. In addition, time-dependent actions of 
vasopressin and oxytocin suggested that the neuropeptides affected both consolidation 
and retrieval of m e m ~ r y . ~  
These initial studies were followed by hundreds of reports that were extensively 
and repeatedly Although the interpretation of the data was never uniform, 
it was generally recognized that vasopressin and oxytocin affected cognitive behavior, 
but certain behavioral actions were not easily reconciled with a mnemonic hypothesis. 
Despite all the knowledge, the mechanisms by which neurohypophysial hormones 
exerted long-term effects on behavior were not understood. This notion concerned 
either network or cellular/molecular levels. For example, it was not specified which 
one( s) of the multiple vasopressinergic systems were involved in learning and memory, 
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and what were the functions of the other circuits. It was well established that vasopres- 
sin was expressed in a number of separate circuits in the brain.8 Although the projec- 
tions of these neurons presupposed involvement in certain functions, the evidence 
favored a high degree of complexity. First, the hypothalamo-neurohypophysial neurons 
seemed to represent the classical neuroendocrine pathway of vasopressin that was 
involved in peripheral physiological effects of antidiuresis and/or pressor activity. 
However, dysfunction of the system also resulted in a behavioral deficit that was 
corrected by peripherally administered vasopressin.’ Second, the medial amygdala/ 
bed nucleus of the stria terminalis vasopressinergic cell bodies that project to the lateral 
septum, ventral hippocampus, locus ceruleus, and the habenular area were proposed 
to be involved in behavioral and physiological thermoregulation?JO convulsive disor- 
ders,” physiological and behavioral events related to late pregnancy and parturi- 
tion,Q13 male sexual behavior,’* and in cellular and behavioral learning and mem- 
ory. 15,16 This vasopressinergic system appeared to be sexually dimorphic and regulated 
by the male gonadal hormone testosterone. l7 Were all these properties represented 
by the very same neuronal network or did diversity exist within the network? A distinct 
receptor system for vasopressin and oxytocinls seemed to provide a solution for the 
question. That vasopressin affected neuronal functions via both vasopressin VI, type 
and oxytocin receptors6-’ opened the possibility that various functions within a network 
were mediated by various (sub)types of receptors. Finally, much knowledge was accu- 
mulated concerning the molecular mechanisms underlying the neuronal actions of 
vasopressin and oxytocin,19 but the molecular basis of long-term effects remained to 
be elucidated. 
In the present paper attention is focused on the contribution of peripheral factors, 
like catecholamines and gonadal hormones, to the action of vasopressin on learning 
and memory processes. The role of the central nucleus of the amygdala in these 
interactions is emphasized. The contribution of central amygdaloid vasopressinergic 
mechanisms to learning and memory was reinforced by the findings that vasopressin 
is a powerful modulator of behavioral passivity and concomitant (parasympathetic) 
physiology, and that this nucleus plays a specific role in coping with conditioned 
environmental challenges. The final discussion is directed to the heterogeneity of 
vasopressinergic mechanisms that influence behavior and physiology, including learn- 
ing and memory. In this context the question is raised as to whether the mnemonic 
action of vasopressin through hypermnesia contributes to mental pathology. 
INTERACTIONS OF ADRENOMEDULLARY HORMONES AND 
VASOPRESSIN IN MEMORY MODULATION 
The interest in investigating the involvement of adrenomedullary hormones in the 
action of vasopressin on learning and memory was initiated by several findings. First, 
vasopressin was known to reverse experimentally induced memory loss (amnesia: see 
BohuszO). Second, the influence of certain drugs (e.g. amphetamine) on memory 
processing appeared to be mediated through adrenomedullary hormones.z1 Third, 
McGaugh and his colleagueszz showed the influence of circulating epinephrine on 
consolidation of memory in intact rats. Postlearning administration of epinephrine 
enhanced memory at low and moderate doses and impaired it at higher doses. Fourth, 
adrenalectomy or adrenomedullectomy resulted in amnesia for an aversive experience 
in male ratsz3 Peripheral administration of low and moderate doses of epinephrine 
reinstated memory. High doses of epinephrine were ineffective in this respect. Norepi- 
nephrine was less effective than epinephrine to normalize memory. But remarkably, 
the effective range was smaller for norepinephrine-that is, lower doses seemed to be 
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ineffective. Based on observations in intact and adrenalectomized rats, it was proposed 
that epinephrine via a p-adrenergic mechanism facilitated memory, whereas norepi- 
nephrine via a-adrenergic receptors served as an amnesic hormone. Finally, adrenergic 
mechanisms in the brain, particularly in the amygdala, were proposed to mediate the 
effect of peripheral catecholamines on memory.22 The memory action of vasopressin 
required an intact noradrenergic transmission in the brain. l5 
Neither postlearning nor preretention administration of vasopressin subcutane- 
ously or intracerebroventricularly reversed the amnesia in adrenalectomized or adre- 
nomedullectomized rats in a passive avoidance task.24 These findings suggested that 
a properly functioning adrenal medulla was essential for the mnemonic action of 
vasopressin. Two alternative hypotheses were developed. First, the release of epineph- 
rine by vasopressin in intact rats might have caused the changes in memory functions. 
Second, epinephrine might act permissively to allow vasopressin to facilitate memory. 
In order to test these hypotheses postlearning and/or preretention administration 
of vasopressin was combined with a peripheral injection of a low, a submaximally 
effective moderate, and an ineffective high dose of epinephrine. Vasopressin caused a 
facilitation of avoidance behavior in epinephrine-pretreated rats provided that the 
amine was administered shortly before the peptide. Thus, the effect of low and moder- 
ate doses of epinephrine (0.00025 to 0.025 pg/kg) were dose-dependently enhanced 
by vasopressin (1 or 6 pg/rat) in adrenalectomized tats, when the two treatments 
were given immediately after the single learning trial (FIG. 1). The very same kind of 
results were obtained with the combination of treatments shortly before the retention 
test. The slight facilitatory effect of epinephrine at low and moderate doses (0.005 to 
0.5 pg/kg) were enhanced by vasopressin in a dose-dependent manner (FIG. 2). 
Combination of epinephrine administration postlearning and vasopressin injection 
before the retention test failed to cause more changes in the avoidance behavior than 
the given dose of amine alone. These results suggested that the presence of circulating 
epinephrine and probably a momentary occupation of a certain subpopulation of p- 
adrenergic receptors were essential to influence memory for a long term by vasopressin. 
Accordingly, the experimental findings favored the second hypothesis-that is, epi- 
nephrine caused a permissive action to allow vasopressin to facilitate memory. 
The results with the high doses of epinephrine were more complicated. The effects 
of vasopressin depended on both the dose of the peptide and the dose of epinephrine 
(FIG. 3). Vasopressin in a dose of 1 pg/rat failed to alter the ceiling effects of epineph- 
rine doses of 0.05 and 0.5 pg/kg, but it substantially facilitated avoidance behavior 
of rats treated with 5.0 or 50.0 pg/kg epinephrine. The higher dose of vasopressin 
(6 &rat) inhibited the effect of 0.05 pg/kg epinephrine, failed to alter the ceiling 
effect of 0.5 pg/kg, but facilitated the behavior of rats receiving 5.0 or 50.0 pg/kg 
epinephrine. In the case of preretention treatment, a slight inhibition was found 
only at the higher dose of vasopressin (6 pg/rat) in combination with 50.0 pg/kg 
epinephrine (FIG. 2). Other combinations, for example, 1 pg vasopressin with 50 or 
125 pg/kg epinephrine or 6 pg vasopressin with 125 pg/kg epinephrine, appeared to 
facilitate avoidance behavior. A postlearning high dose of epinephrine and preretention 
administration of vasopressin were not effective. 
The results suggested that vasopressin reversed the amnesic effects of high doses 
of epinephrine provided that a-adrenergic receptors were probably occupied by the 
catecholamine. The inhibitory effect of vasopressin was probably related to overarousal 
as induced by the peptide superimposed on a mixed p- and a-adrenergic effect of 
epinephrine. The effects of various doses of postlearning vasopressin often showed an 
inverted U-shaped curve.25 
The results described here were replicated with adrenomedullecromized instead 
of adrenalectomized rats, intracerebroventricdar instead of peripheral injection of 
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FIGURE 1. The effects of postlearning administration epinephrine (EPI) and/or arginine- 
vasopressin (AVP) on the retention of a one-trial learning passive-avoidance response in adrenalec- 
tomized rats. Latency to reenter the former shock compartment one day after learning was used 
as the measure of memory. Sham-operated rats scored the maximal latency of 300 sec. The EPI 
doses were expressed in pgkg b.w., whereas the AVP dose was expressed in pg/pkr rat of an 
average of 250 g body weight. Treatments were given subcutaneously. Seven to eight animals 
per group. 
vasopressin, and with administration of norepinephrine in high doses. Accordingly, 
the findings were not affected by the presence or absence of circulating corticosterone 
and by the route of administration of the peptide. Experiments are in progress to 
determine the nature of p- and a-adrenergic receptors that were involved in the 
memory-stimulating or inhibitory effects of circulating catecholamines. 
EPINEPHRINE, VASOPRESSIN, AND THE AVOIDANCE 
BEHAVIOR OF BRATnEBORO RATS 
In order to determine whether a cooperative action between vasopressin and 
epinephrine was of a general validity, the effects of adrenalectomy, vasopressin, and 
epinephrine treatments were also investigated in male Brattleboro rats homozygous 
or heterozygous for hereditary hypothalamic diabetes insipidus.z6 Although there was 
no general consensus about the deficits in learning and memory of these Long-Evans- 
derived pigmented rats:’ probably due to both procedural and substrain differences, 
the male homozygous rats showed serious retention deficits in our  hand^.^^.^^ The 
deficit was corrected by either postlearning or preretention vasopressin. 
BOHUS et al.: LEARNING AND MEMORY PROCESSING 
POSTLEARNING - ADX/SA ADX/EPIEZW~ ADXIEPI ADX/EPI EZZi ADXIEPI 
0.05 0.5 5.0 50.0 
289 
SA L AVP 1.0 AVP 6.0 
POSTLEARNING 
FIGURE 2. The effects of preretention administration of epinephrine and/or arginine-vasopres- 
sin on the passive avoidance behavior of adrenalectomized rats. Treatments were given 60 min 
before the test. Seven to nine rats per group. For abbreviations and other details see FIGURE 1. 
FIGURE 4 shows that peripheral administration of two doses of vasopressin facili- 
tated avoidance behavior of sham-operated homozygous and heterozygous rats. The 
same doses of the peptide were not effective in the adrenalectomized Brattleboro 
rats. In addition, corticosterone substitution did not change the ineffectiveness of 
vasopressin. 
FIGURE 5 shows that an intermediate and a high dose of epinephrine did not 
facilitate the avoidance behavior of either the sham-operated or the adrenalectomized 
homozygous diabetes insipidus rats. In the heterozygous line both doses were effective 
in the sham-operated animals, whereas the intermediate dose was facilitating avoidance 
behavior in the adrenalectomized rats. The ineffectiveness of the high dose of epineph- 
rine was in agreement with the findings in adrenalectomized Wistar rats. The sensitivity 
of intact and adrenomedullectomized Wistar rats towards epinephrine was lower than 
in the adrenalectomized animals.23 Taken together, the results obtained in Brattleboro 
rats suggested that the action of peripheral epinephrine on memory processes required 
vasopressin for cooperative action. 
Vasopressin is not the only neuropeptide that affects learning and memory pro- 
cesses.21 The question was asked whether the mnemonic action of these peptides used 
the same mechanisms as did vasopressin. Therefore, an ACTH-related peptide, ACTH 
410, and an endogenous opioid peptide, met-enkephalin, were also administered to 
adrenalectomized Brattleboro rats homozygous for hereditary diabetes insipidus. It 
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FIGURE 3. The effect of postlearning administration of epinephrine in moderate and high 
doses and/or of arginine-vasopressin on passive-avoidance retention of adrenalectomized rats. 
Seven to eight animals per group. For further details, see FIGURE 1 .  
the avoidance behavior of the Brattleboro rats. These results suggested that ACTH 
410 and met-enkephalin used a different access to memory processing than vasopressin 
and epinephrine. 
SEX DEPENDENCE OF THE ANTIAMNESIC EFFECT OP 
VASOPRESSIN 
A part of the vasopressinergic innervation in the limbic forebrain of the rat is 
androgen-dependent. Vasopressin containing fiber density in the lateral septum was 
higher in males than in females. Castration in the males reduced the density to the 
levels of females, but testosterone replacement normalized it. 17,30 Testosterone modu- 
lated the expression of the vasopressin gene in the neurons of the bed nucleus of the 
stria terminalis of adult male rats.31 At the behavioral level vasopressin appeared to 
mimic androgen effects on male sexual and agonistic behavior following castration. 14-32 
The involvement of the androgen-dependent vasopressinergic system in social memory 
processes in male, but not in female, rats was also ~ u g g e s t e d . ~ ~ - ~ ~  
Our approach to investigate sex dependence of the mnemonic effect of vasopressin 
was based on the robust antiamnesic effects of peripheral or central administration of 
vasopressin. 19,37 In addition, habituation of open-field exploration was selected as a 
mnemonic test in order to avoid complications presented by sex differences in conven- 
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FIGURE 4. Postlearning arginine-vasopressin administration and avoidance behavior of sham- 
operated (SHAM) or adrenalectomized (ADX) and corticosterone (CS)-supplemented Brat- 
tleboro rats either homozygous (HO-DI) or heterozygous (HE-DI) for hereditary hypothalamic 
diabetes insipidus. Five rats per group. For hrther details, see FIGURE 1. 
tional learning and memory tests. Adult male and female rats explored a novel field 
rather vigorously at the first exposure. A substantial reduction of exploratory activity 
upon repeated exposure suggested memory of the environment. Injection of pentylene- 
tetrazol that induced tonic-clonic seizure behavior, immediately after the first expo- 
sure, that is postlearning, resulted in a partial amnesia for the explored environment: 
the rats showed much less reduction in exploratory activity than their controls. The 
degree of amnesia was more or less the same for both sexes. FIGURE 6 shows that 
administration of vasopressin before the second test dose-dependently reversed amnesia 
in the males, whereas the treatment was without significant effect in the females. 
These results suggested sex dependence of vasopressin for reversing experimental 
amnesia. Experiments in progress should present the final evidence that androgen- 
dependent projection areas from the bed nucleus of stria terminalis were, involved. 
The central amygdala may be a site through which pentylenetetrazol-induced amnesia 
could be reversed by vas~press in .~~ 
INVOLVEMENT OF THE CENTRAL AMYGDALA IN THE 
MODULATION OF MEMORY BY VASOPRESSIN 
Despite the neuroanatomical and functional multiplicity of the brain vasopressiner- 
gic ~ y s t e r n s , * J ~ ~ ~ ~  there were a number of reasons to focus our interest on the central 
amygdaloid nucleus as a probable key structure for mediating a series of effects of 
vasopressin that are related to learning and memory. First, the central amygdala ap- 
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PIGURE 5. Postlearning administration of epinephrine and passive avoidance behavior in Brat- 
tleboro rats. For further details see FIGURES 1 and 4. 
peared to receive vasopressinergic innervation probably from the bed nucleus of the 
stria terminalis, whereas oxytocinergic pathways were known to arise from the hypo- 
thalamic paraventricular nuclei.38 It contained a high density of vasopressin and oxyto 
cin receptors.3941 Second, the functional heterogeneity of this nucleus from a neurobi- 
ological point of view predisposed it as a major integrator of external and internal 
influences on adaptation, particularly on learning and memory. The central amygdala 
appeared to play a central role in the initiation-acquisition and consolidation of 
the environmental information (see Aggleton"). According to McGaugh's view, the 
amygdala served to modulate the storage of information at other brain sites via the 
activation of physiological systems by affective  tim mu la ti on.'^ This view implied that 
the amygdala was the site of generalized modulation of memory storage by hormones 
and neurotransmitter systems via the activation or inhibition of noradrenergic input 
to the structure. Interestingly, unimpaired noradrenergic neurotransmission to the 
limbic forebrain appeared to be essential in facilitating memory by vasopressin.15 Ac- 
cordingly, the central amygdala appeared to be a likely candidate of mutual interactions 
between circulating epinephrine and centrally (or peripherally) available vasopressin. 
A low dose of vasopressin (20 pg) infused into the central amygdala of resting 
rats in their home cage caused a decrease in the heart rate that lasted for at least one 
hour afier termination of the infusion. The resting behavior of the nonstressed rats 
did not change with this dose of v a s o p r e ~ i n . ~ ~  A higher dose of vasopressin (200 pg) 
and low doses of oxytocin (20 and 200 pg) failed to affect heart rate and behavior. 
The highest dose of vasopressin and oxytocin (2 ng) elicited a transient acceleration 
of heart rate with concomitant increase in behavioral activity. These latter effects were 
blocked by pretreatment with a selective oxytocin antagonist, dPTyr(Me)OVT. All 
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FIGURE 6. Sex dependence of the reversal of pentylenetetrazol (PTZ)-induced amnesia for 
exploration of a novel environment by arginine-vasopressin in male and female rats. PTZ was 
administered i.p. immediately after the first exposure to the novel open-field in a dose of 4.5 
mg/kg. AVP was administered 60 min before the second exposure to the field. Exploratory 
scores represent the number of floor units entered on the second day. Broken lines show the 
behavior of nonamnesic controls (PTZ treatment six hours after the first exposure). Six animals 
per group. 
doses of vasopressin and oxytocin increased the circulating corticosterone levels, but 
failed to affect plasma catecholamine concentrations. 
These results deserved attention from a few different point of view. First, as in a 
number of conditioned behavioral ~ i tua t ions ,~J~  vasopressin and oxytocin exerted an 
opposite physiological effect probably activating and inhibiting the output to the 
dorsal motor nucleus via a monosynaptic connection.& However, activation of the 
vagus was probably evoked via vasopressin receptor of V1, type, and the inhibition via 
the oxytocin receptor in the central amygdala. The elevation of the corticosterone 
level, that is, activation of the hypothalamo-hypophysial-adrenal system via the paraven- 
tricular hypothalamic nuclei4' by both vasopressin and oxytocin, was elicited via the 
oxytocin receptor. Facilitation of active and passive avoidance behaviors by vasopressin 
(and its analogues) appeared to be mediated via the oxytocin receptor in the brain,7 
for which vasopressin was an agonist and oxytocin an inverse agonist. In contrast, it 
was shown that the action of peripheral vasopressin on various learning and memory 
tasks was blocked by the vasopressor antagonist dP'ITyr( Me)arginine-vasopressin.6 
Accordingly, vasopressin effects on memory processes may be induced via mechanisms 
that aroused the sympathetic system, but also through mechanisms that caused vagal 
activation. Indeed, abundant evidence suggested that vasopressin induced behavioral 
arrest and passivity accompanied by vagal activation and inhibition of sympathetic 
outflow.44 
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VASOPRESSIN, BEHAVIORAL IMMOBILITY, AND 
PARASYMPATHETIC ACTIVATION 
Vasopressin enhanced the duration of behavioral arrest and immobility in response 
to the mild stressor of sudden silence superimposed on low-intensity background noise. 
The peptide also intensified the bradycardiac (vagally controlled) heart rate response 
that accompanied the behavioral arrest in young adult rats. In addition, the bradycar- 
diac reaction that was absent in aged rats appeared to be restored by vas~pressin.~~ 
Attenuated parasympathetic activation, as observed in aged rats in a one-trial learning 
conditioned immobility situation, was also restored by vasopressin administration .% 
Amphetamine, but not apomorphine, was also effective in aged rats in both the sudden 
silence and conditioned immobility tests, suggesting the involvement of noradrenergic 
rather than dopaminergic mechanisms.** 
The bradycardiac (vagal) component of conditioned emotional responses were 
enhanced in a number of other situations where immobility or withdrawal represented 
the behavioral component.44 The behavioral and cardiac response was absent under 
such conditions in Brattleboro rats homozygous for hereditary hypothalamic diabetes 
insipidus. Administration of vasopressin restored these responses.49 
Neonatal functioning of the vasopressinergic systems in the brain appeared to have 
a long-lasting consequence on (im)mobility behavior, and behavioral and autonomic 
correlates of memory processes. Peripheral administration of vasopressin on postnatal 
days 3 through 7 in a high (10 pg/kg) and a low (1 pg/kg) dose to male Wistar rats 
decreased adult immobility, reduced the bradycardiac response during conditioned 
immobility behavior, and impaired memory processes related to emotional stress. These 
results were interpreted as the consequence of decreased sensitivity of the vasopressin 
receptors towards endogenous vasopressin in the adulthood via a neonatal downregula- 
tion of receptors.5o Postnatal vasopressin treatment appeared to downregulate this 
peptide’s receptors in the adult kidney and reduced antidiuretic r e s p o n ~ e . ~ ~ , ~ ~  Impair- 
ment of adult memory by chronic prenatal administration of vasopressin was also 
observed in the rat.53 
VASOPRESSIN: A CENTRAL NERVOUS AND PERIPHERAL 
PEPTIDE OF PASSIVE COPING 
Manipulation of the vasopressinergic systems genetically, perinatally, in the adult 
and aged rats resulted in changes in learning and memory processing as reflected in 
the behavioral and autonomic parameters. Vasopressin enhances passivity and parasym- 
pathetic activation, whereas impairment of vasopressinergic function resulted in more 
active behavior with memory deficits and sympathetic activation. It became clear that 
to learn about the environment and to cope using memory allowed more than one 
expression of adaptation. Animals (mice, rats, monkeys) and men might adopt two 
kinds of strategies to cope. The active strategy was characterized by rapid learning of 
active responses (fight or flight) towards the social and nonsocial environment, a high 
degree of stereotyped behavior and a low degree of immobility and attention. The 
physiological characteristic was described as a high degree of sympathetic activation. 
In contrast, the passive strategy was specified as a conservation/withdrawal response 
pattern with a high degree of immobility and attention, and with a low degree of fight/ 
flight behavior. A high degree ofparasympathetic and pituitary-adrenal activation were 
the physiological attributes of this coping 
In neurophysiological and neuroanatomical studies, a brain circuit was constructed, 
termed as expectancy/anticipatory response pattern circuit, through which vasopressin 
BOHUS et d.: LEARNING AND MEMORY PROCESSING 295 
might modulate passive ways of coping.55 The key structures of the circuit were the 
central nucleus of the amygdala, the bed nucleus of the stria terminalis, the paraven- 
tricular and lateral hypothalamic nuclei, the cuneiform, parabrachial nuclei, and n u  
cleus of the tractus solitarius at lower brain level. The circuits could be characterized 
by long peptidergic neuronal connections between the nuclei. The circuit appeared 
to have extensive outputs to parasympathetic and sympathetic autonomic, and hypo- 
physeal neuroendocrine systems. In addition, cognitive and motor outputs could 
also be recognized through cortical and limbic afferents. Vasopressinergic neurons 
represented an essential part of the circuit. Descending connections to the lower 
brainstem and spinal autonomic areas might be vasopressinergic (or oxytocinergic) . 
As far as the memory processes are concerned, action of vasopressin in the central 
nucleus of the amygdala via vasopressin, and oxytocin receptors may represent the 
memorial component of the passive coping. The central amygdala was essential at  the 
phase of learning new information, probably by assuring the optimal neuroendocrine 
and physiological state for consolidation processes. Activation of the sympatho-adrenal 
and the pituitary-adrenocortical systems appeared to be essential components of this 
state. If the central amygdala was damaged before learning, the animals were unable 
to achieve the optimal state.56 
Findings obtained with rats and mice selected for the use of practically only passive 
or only active coping strategies via selection for active avoidance behavior or aggressive 
attack latency,57,58 opened new avenues for investigating the physiological involvement 
of vasopressin in passive coping mechanisms. I t  was found that vasopressin infusion 
into the central amygdala of Roman low-avoidance rats, which cope passively, potenti- 
ated the conditioned emotional bradycardia and immobility. Actively coping Roman 
high-avoidance rats practically did not change their behavior and heart rate afier 
vasopressin inhsion. In addition, it was found that rhe vasopressinergic fiber system 
in the lateral septum was more dense and more vasopressin-containing cell bodies in 
the bed nucleus of the stria terminalis were present in the brain of passively coping 
long attack latency mice in comparison with the actively coping short attack latency 
mice. Castration resulted in the disappearance of vasopressin in both lines, suggesting 
the testosterone dependence of the innervation. Interestingly, a higher number of 
immunocytochemically labeled vasopressin neurons was found in the suprachiasmatic 
nuclei, but not in the paraventricular nuclei of the hypothalamus in the brain of mice 
selected for a low level of nest-building behavior in comparison with mice selected for 
a high level of nest-building behavi~r.~’ Further studies on the genetics and the 
ontogeny of the peptidergic network and of the receptors should contribute to an 
understanding of the neurobiology of the differences in relation to coping strategy. 
CONCLUDING REMARKS 
The starting concept of this paper was to collect data that allow an interpretation 
(or interpretations) of the heterogeneity of the mnemonic action of neurohypophyseal 
hormones, in particular of vasopressin. A few general aspects of the findings may be 
taken as major conclusions. First, peripheral hormones played an important role in 
the action of vasopressin on memory processes. The actions may be permissive by 
temporary occupation of certain receptor populations (e.g., adrenergic receptors), or 
of a more long-term nature as in the case of gonadal hormones. While  the gonadal 
hormones undoubtedly acted on the cells at the gene level of the forebrain vasopressin- 
ergic system, the site(s) of interaction between catecholamines and vasopressin remain 
to be specified. It is generally maintained that catecholamines cannot pass the blood- 
brain barrier.58 It is likely that the message from the circulating hormones reaches the 
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amygdala, a major site of action, via adrenergic receptor activation in the periphery 
and visceral derents to the brain.22 That peripheral vasopressin might use visceral 
derentation via changes in the blood pressure has repeatedly been suggested.6 What- 
ever the mechanism may be, our result showed that the catecholamine-vasopressin 
interaction did not depend on the peripheral o r  central availability of the peptide. It 
is likely that there is mutual cooperation between the mechanisms operating in the two 
compartments. Peripheral administration of a behaviorally active dose of vasopressin- 
enhanced adrenal corticosterone output failed to change epinephrine levels, but inhib- 
ited resting and novelty-induced elevation of norepinephrine levels. The effects lasted 
longer than changes in, for example, blood pressure. The inhibition of sympathetic 
outflow by the peptide may be a mechanism by which an a-adrenoceptor-induced 
amnesia is attenuated. Furthermore, sympathetic inhibition may contribute to the 
parasympathetic outflow as induced by genuine central nervous vasopressinergic activa- 
tion at the level of the central amygdala or brainstem nuclei.59 
The parasympathetic component represented an essential chain of the events in 
the passive way of coping and its relation to memory processes. Evidence suggested 
that inhibition of the vagal heart response by the peripherally acting methylatropine 
also attenuates immobility behavior accompanying the conditioned emotional re- 
sponse. More data are becoming available indicating that vasopressin enhances expres- 
sion of behavioral elements like selective attention, preferential processing of dominant 
information,6l and so forth, that are components of passive coping ~ t r a t egy . '~*~~  The 
relation of these effects to memory processes is, however, not always clear. More 
importantly, recent findings showed that vasopressin was essential for conditioned 
immobility.62 
One may, however, raise the question how the hypothesis that vasopressin primar- 
ily serves those mnemonic processes that belong to the category of passive coping can 
be reconciled with findings like long-term maintenance of active avoidance behavior 
in the absence of punishment. This kind of hyperamnesic effect may be synonymous 
with compulsive behavior. Similarly, disrupting ongoing behavior often reported in 
appetitive situations (e.g. see Alli0F3) or induction of taste or place aversion by 
vasopressin is a reflection of phobic states. If this argumentation is true, the use of 
vasopressin in different models may serve to study either physiological or pathological 
processes. 
REFERENCES 
1. DE WIED, D. 1965. The influence of the posterior and intermediate lobe of the pituitary 
and pituitary peptides on the maintenance of a conditioned avoidance response in rats. 
Int. J. Neuropharmacol. 4 157-167. 
2. BOHUS, B., W. H. GISPEN & D. DE WIED. 1973. Effects of lysine vasopressin and ACTH 
410 on conditioned avoidance behavior of hypophysectomized rats. Neuroendocrinol- 
DE WIED, D. & B. BOHUS. 1966. Long-term and short-term effects on retention of a 
conditioned avoidance response in rats by treatment with long acting pitressin and alpha- 
MSH. Nature 212: 1484-1486. 
4. BOHUS, B., G. L. KOVACS & D. DE WIED. 1978. Omocin, vasopressin and memow 
O ~ Y  11: 137-143. 
3. 
processes: Opposite effects on consolidation and retheval proceLes. Brain Res. 157: 
414-417. 
5. STRUPP, B. J. & D. LEVITSKY. 1985. A mnemonic role for vasopressin: The evidence for 
and against. Neurosci. Biobehav. Rev. 9: 399-411. 
6. KOOB, G. F., C. LEBRUN, R-M. BLUTHE, R DANTZER, D. M. DORSA & M. LE MOAL. 
1991. Vasopressin and learning: Peripheral and central mechanisms. In Peripheral Signal- 




















ling of the Brain. R.C.A. Frederickson, J.  L. McGaugh & D. L. Felten, Eds.: 351 -363. 
Hogrefe & Huber. Toronto. 
DE WIED, D. 1991. The effect of neurohypophyseal hormones and related peptides on 
learning and memory processes. In Peripheral Signalling of the Brain. R. C. A. Fred- 
rickson, J. L. McGaugh & D. L. Felten, Eds.: 335-350. Hogrefe & Huber. Toronto. 
BUIJS, R. M. 1983. Vasopressin and oxytocin-their role in neurotransmission. Pharmacol. 
Ther. 22: 127-141. 
HERMES, M. L. H .  J., R. M. BUIJS, M. MASON-PEVET, T. P. VAN DER WOUDE, P. PEVET, 
R. BRENKLE & R. KIRSCH. 1990. Central vasopressin infusion prevents hibernation in 
the European hamster (Cricetus cricetus). Proc. Natl. Acad. Sci. USA 86: 6408-6411. 
KMTING, N. W. 1989. Criteria for establishing a physiological role for brain peptides. A 
case in point: The role of vasopressin in thermoregulation during fever and antipyresis. 
Brain Res. Rev. 14: 143-153. 
P I ~ M A N ,  Q. J., A. NAYLOR, P. POULIN, J. DISTURNAL, W. L. VEALE, S. M.  ARTIN IN, 
T. J. MALKINSON & B. MATHIESON. 1988. The role of vasopressin as an antipyreticnin 
the ventral septal area and its possible involvement in convulsive disorders. Brain Res. 
CALDWLL, J. D., E. R. GREER, M. F. JOHNSON, A. J.  PRANGE & C. A. PEDERSEN. 1987. 
Oxytocin and vasopressin immunoreactivity in hypothalamic extrahypothalamic sites in 
late pregnant and postpartum rats. Neuroendocrinology 46: 39-47. 
LANDGRAF, R., I. NEUMA" & Q. J. PIITMAN. 1991. Septal and hippocampal release of 
vasopressin and oxytocin during late pregnancy and parturition in the rat. Neuroendocrin- 
KOOLHAAS, J. M., E. MOOR, Y. HIEMSTRA& B. BOHIJS. 1991. The testosterone-dependent 
vasopressinergic neurons in the medial amygdala and lateral septum: Involvement in 
social behaviour of male rats. In Vasopressin. S. Jard & R. Jemison, Eds.: 213-219. 
Libbey Eurotext. Montpellier. 
KOVACS, G. L., B. BOHUS & D. H. G. VERSTEEG. 1979. The effects vasopressin on 
memory processes: Role of noradrenergic transmission. Neuroscience 4 1529- 1537. 
VAN DEN HOOFF, P., I .  J. A. URBAN & D. DE WIED. 1989. Vasopressin maintains long- 
term potentiation in rat lateral septum slices. Brain Res. 505: 181-186. 
DE VRIES, G. J., R. M. BIJIJS, F. W. VAN LEEUWEN, A. R. CAFFE & D. F. SWAAB. 1985. 
The vasopressinergic innervation of the brain in normal and castrated rats. J. Comp. 
Neurol. 223: 236-254. 
JARD, S., C. BARBERIS, S. AUDIGER & E. TRIBOLLET. 1987. Neurohypophyseal hormone 
receptor systems in brain and periphery. Progr. Brain Res. 72: 173-187. 
BRINTON, R. E. 1991. Biochemical correlates of learning and memory. In Learning and 
Memory. A Biological View. J. L. Martinez & R. P. Kesner, Eds.: 199-257. Academic 
Press. San Diego. 
BOHUS, B. 1982. Neuropeptides and memory. In The Expression of Knowledge. R. L. 
Isaacson & N. E. Spear, Eds.: 141-177. Plenum. New York. 
MARTINEZ, J. L., JR., S. B. WEINBERGER, P. H. JANAK, G. SCHULTEIS, S. SHIBANOKI & 
K. ISHIKAWA. 1991. How hormones influence learning and memory. In Peripheral 
Signalling of the Brain. R. C. A. Fredrickson, J. L. McGaugh & D. L. Felten, Eds.: 
365-378. Hogrefe & Huber. Toronto. 
MCGAUGH, J. L. 1989. Involvement of hormonal and neuromodulatory systems in the 
regulation of memory storage. Ann. Rev. Neurosci. 12: 255-287. 
BORRELL, J., E. R. DE KLOET, D. H .  G. VERSTEEG & B. BOHUS. 1983. Inhibitory 
avoidance deficit following short-term adrenalectomy in the rat. The role of adrenal 
catecholamines. Behav. Neural Biol. 39: 241-258. 
BORRELL, J., E. R. DE KLOET, D. H. G. VERSTEEG, B. BOHUS & D. DE WIED. 1984. 
Neuropeptides and memory: Interactions with peripheral catecholamines. In Stress. The 
Role of Catecholamines and Other Neurotransmitters. E. Usdin, R. Kvetnansky & J. 
Axelrod, Eds.: 391-402. Gordon & Breach. New York. 
HAGAN, J., B. BOHUS & D. DE WIED. 1982. Post-training vasopressin injections may 
facilitate or  delay shuttle-box avoidance extinction. Behav. Neural Biol. 36: 21 1-228. 
Bull. 20: 887-892. 
O I O ~ Y  54: 378-383. 




















BORRELL, J., S. DEL CERRO, C. GUAZA, M. ZUBIAUR, D. DE WIED & B. BOHUS. 1985. 
Interactions between adrenaline and neuropeptides on modulation of memory processes. 
In  Contemporary Psychology: Biological Processes and Theoretical Issues. J. L. 
McGaugh, Ed.: 17-36. North-Holland. Amsterdam. 
LORENZINI, C. A., C. BUCHERELLI, A. GIACHE'ITI & G. TASSONI. 1991. The behavior 
of the homozygous and heterozygous sub-types of rats which are genetically selected for 
diabetes insipidus: A comparison with LongEvans and Wistar stocks. Experientia 47: 
BOHUS, B., TJ. B. VAN WIMERSMA GREIDANUS & D. DE WIED. 1975. Behavioral and 
endocrine responses of rats with hereditary hypothalamic diabetes insipidus (Brattleboro 
strain). Physiol. Behav. 14: 609-615. 
DE WIED, D., B. BOHUS & TJ. B. VAN WIMERSMA GREIDANUS. 1975. Memory deficits 
in rats with hereditary diabetes insipidus. Brain Res. 85: 152-156. 
DE VRIES, G. J., R. M. BUIJS & A. A. SHRITER. 1984. Gonadal hormone action on the 
morphology of the vasopressinergic innervation of the adult rat brain. Brain Res. 298: 
MILLER, M. A,,  J. H. URBAN & D. M. DORSA. 1989. Steroid dependency of vasopressin 
neurons in the bed nucleus ofthe stria terminalis by in situ hybridizitation. Endocrinology 
BOHUS, B. & J. M. KOOLHAAS. 1985. Neuropeptides, neurotransmitters and memory: 
Sociosexual aspects. In Contemporary Psychology. Biological Processes and Theoretical 
Issues. J. L. McGaugh, Ed.: 3-16. Elsevier-North-Holland. Amsterdam. 
DANTZER, R., R-M. BLUTHE, G. F. KOOB & M. LE MOAL. 1987. Modulation of social 
memory in male rats by neurohypophysial peptides. Psychopharmacology 91: 363-348. 
LE MOAL, M., R. DANTZER, B. MICHAUD & G. F. KOOB. 1987. Centrally injected arginine 
vasopressin (AVP) facilitates social memory in rats. Neurosci. Lett. 77: 353-359. 
DANTZER, R., G. F. KOOB, R-M. BLUTHE & M. LE MOAL. 1988. Septal vasopressin 
modulates social memory in male rats. Brain Res. 457: 143- 147. 
BLUTHE, R-M. & R DANTZER. 1990. Social recognition does not involve vasopressinergic 
neurotransmission in female rats. Brain Res. 535: 301-304. 
B o w s ,  B., L. CONTI, G. L. KOVACS & D. H. G. VERSTEEG. 1982. Modulation of memory 
processes by neuropeptides: Interaction with neurotransmitter systems. In Neuronal 
Plasticity and Memory Formation. C. Ajmone Marsan & H. Matthies, Eds.: 75-87. 
Raven. New York. 
DE VRIES, G. J. & R. M. BUIJS. 1983. The origin of the vasopressinergic innervation of 
the rat brain with special reference to the lateral septum. Brain Res. 273: 307-317. 
DE KLOET, E. R., F. RO-ITEVEEL, TH. D. VOORHUIS & M. TERLOU. 1985. Topography 
of binding sites for neurohypophysial hormones in rat brain. Eur. J. Pharmacol. 110: 
VAN LEEUWEN, F. W., E. M. VAN DER BEEK, J. J. VAN HEERIKHUIZE, P. WOLTERS, G. 
VAN DER MEULEN & Y. P. WAN. 1987. Quantitative light microscopic autoradiographic 
localization of binding sites labelled with [3H]vasopressin antagonist d(CH2)5Tyr 
(ME)VP in the rat brain, pituitary and kidney. Neurosci. Lm. 80: 121-126. 
TRIBOLLET, E., C. BARBERIS, . JARD, M. DUBOIS-DAUPHIN & J. J. DREIFUSS. 1988. 
Localization and pharmacological characterization of high affinity binding sites for vaso- 
pressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res. 
AGGLETON, J. P. 1992. The Amygdala. Neurobiological Aspects of Emotion, Memory, 
and Mental Dysfunction. Wiley-Liss. New York. 
MCGAUGH, J. L., I. B. INTROINI-COLLISON, L.CAHILL, M. KIM & K. C. LIANG. 1992. 
Involvement of the amygdala in neuromodulatory influences on memory storage. In The 
Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. J ,  
P. Aggleton, Ed.: 431-451. Wiley-Liss. New York. 
BOHUS, B., J .  M. KOOLI~AAS, C. NYAKAS, P. G. M. LUITEN, C. A. M. VERSTEEG, S. 
M. KORTE, D. JAARSMA, W. TIMMERMAN & W. EISENGA. 1990. Neuropeptides and 






BOHUS et d.: LEARNING AND MEMORY PROCESSING 299 
tides. In Psychobiology ofStress. S. Puglisi-Allegra & A. Oliverio, Eds.: 103-123. Kluwer 
Academic Publ. Dordrecht. 
ROOZENDAAL, B., G. H. M. SCHOORLEMMER, A WIERSMA, S. SLLJYTER, P. DRISCOLL, J.
M. KOOLHAAS & B. BOHUS. 1992. Opposite effects of central amygdaloid vasopressin 
and oxytocin on the regulation of conditioned stress responses in male rats. Ann. N.Y. 
Acad. Sci. 652: 460-461. 
VEENING, J.  G . ,  L. W. SWANSON & P. E. SAWCHENKO. 1984. The organization of the 
projections from the central nucleus of the amygdala to brainstem sites involved in central 
autonomic regulation: A combined retrograde transport-immunohistochemical study. 
Brain Res. 303: 337-357. 
GRAY, T. S., M. E. CARNEY & D. J. MAGNUSON. 1989. Direct projections from the 
central amygdaloid nucleus to the hypothalamic paraventricular nucleus: Possible role 
in stress-induced adrenocorticotropin release. Neuroendocrinology 50: 433-446. 
BWALDA, B., J. M. KOOLHAAS & B. BOHUS. 1992. Behavioral and cardiac responses to 
mild stress in young and aged rats: Effects of amphetamine and vasopressin. Physiol. 
Behav. 51: 211-216. 
BOHUS, B. 1977. Pituitary neuropeptides, emotional behavior and cardiac responses. Progr. 
Brain Res. 47: 277-288. 
BWALDA, B., C.  NYAKAS, J. M. KOOLHAAS & B. BOHUS. 1991. Effects of neonatal 
administration of vasopressin on behavioral and cardiac responses. Physiol. Behav. 50: 
51. HANDELMAN, G. E. & S. C. SAYSON. 1984. Neonatal exposure to vasopressin decreases 
vasopressin binding sites in the adult kidney. Peptides 5: 1217-1219. 
52. HANDELMAN, G. E., J. T .  RUSSELL, H .  GAINER, R. ZERBE & M. BAYORH. 1983. 
Vasopressin administration to neonatal rats reduces antidiuretic response in adult kidneys. 
Peptides 4: 827-832. 
53. TINIUS, T.  P.,  B. E. BECKWITH & D. W. PREUSSLER. 1987. Prenatal administration of 
arginine vasopressin impairs memory retrieval in adult rats. Peptides 8: 493-499. 
54. KOOLHAAS, J. M. & B. BOHIJS. 1989. Social control in relation to neuroendocrine and 
immunological responses. In Stress, Personal Control and Health. A. Steptoe & A. 
Appels, Eds.: 295-305. Wiley. London. 
55. BOHIJS, B., J. M. KOOLHAAS, P. G. M. LUITEN, C. A. M. VERSTEEG, M. S. KORTE & D. 
JAARSMA. 1989. Vasopressin and related peptides: Involvement in central cardiovascular 
regulation. In Hypertension, Brain Catecholamines and Peptides. F. Nijkamp & D. De 
Wied, Eds.: 99-1 10. Elsevier. Amsterdam. 
56. ROOZENDAAL, B., G. H.  M. SCHOORLEMMER, J. M. KOOLHAAS & B. BOHIJS. 1992. 
Cardiac, neuroendocrine and behavioral effects of central amygdaloid vasopressinergic 
and oxytocinergic mechanisms under stress-free condhons in rat. J. Neuroendocrinol. 
4: 483-489. 
BULT, A,,  E. A. VAN DER ZEE, J .  C.  COMPAAN & C. B. LYNCH. 1992. Differences in 
the number of arginine-vasopressin immunoreactive neurons exist in the suprachiasmatic 
nuclei of house mice selected for differences in nest-buildmg behavior. Brain Res. 578: 
335-338. 
WEIL-MALHERBE, H., J. AXELROD & R. TOMCHICK. 1959. Blood-brain barrier for adren- 
alin. Science 129: 1226- 1228. 
BWALDA, B., C. NYAKAS, J. M. KOOLHAAS& B. BOHWS. 1993. Behavioral and neuroendo- 
crine effects of vasopressin in resting and stress conditions. Physiol. Behav. In press. 
ROOZENDAAL, B. 1992. Central Amygdala, Stress and Adaptation. Ph.D. dissertation. 
University of Groningen, the Netherlands. 
BUNSEY, M., D. KRAMER, M. KESLER & B. J. STRUPP. 1990. A vasopressin metabolite 
increases attentional selectivity. Behav. Neurosci. 104: 277-287. 
STOEHR, J. D., S. CHENG, F. MCCANN & W. G. NORTH. 1991. Homozygous Brattleboro 
rats display attenuated conditioned freezing response. S o c .  Neurosci. Abstr. 17: 1416. 
ALLIOT, J. 1990. Effects of vasopressin on spontaneous black-white choices in a T-maze. 
Pharmacol. Biochem. Behav. 35: 981-987. 
45. 
46. 
47. 
48. 
49. 
50. 
929-932. 
57. 
58. 
59. 
60. 
61. 
62. 
63. 
